Zoetis Inc (ZTS) stock news · P/E 25, rev $2.47B
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
This ZTS news page leads with what Zoetis Inc filed — not a scraped headline mill.
No cached 8-K sentence for ZTS yet. We will not pad this page with generic market recap.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ZTS stock page; for the tape open the quote page.
Not investment advice.